Press Releases United Therapeutics Corporation

Equities

UTHR

US91307C1027

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 17:29:53 15/07/2025 BST			5-day change	1st Jan Change
293.20 ^USD	-1.50%		-0.36%	-16.86%

07-14	United Therapeutics Offers Favorable Profile Ahead of Key Data, Oppenheimer Says	MT
06-30	United Therapeutics' Tyvaso to Benefit from Q2 Seasonality, UBS Says	MT

Press Releases

United Therapeutics and Intermountain Health Announce the First Patient Treated With External Liver Support Using a Bioengineered Liver	06-24	BU
United Therapeutics Corporation Concludes Enrollment of the ADVANCE OUTCOMES Study of Ralinepag for the Treatment of Pulmonary Arterial Hypertension	06-23	BU
United Therapeutics: Q1 Earnings Snapshot	04-30	AQ
United Therapeutics Corporation Reports First Quarter 2025 Financial Results	04-30	BU
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2025 International Conference	04-21	BU
United Therapeutics Corporation to Report First Quarter 2025 Financial Results Before Market Open on Wednesday, April 30, 2025	04-16	BU
United Therapeutics Corporation to Feature Clinical Data Across its Commercial and Development Portfolio at the International Society for Heart and Lung Transplantation 45th Annual Meeting and Scientific Sessions	04-04	BU
United Therapeutics Named to '100 Best Companies to Work For' in 2025 by Fortune Media and Great Place to Work	04-03	AQ
United Therapeutics Named to ‘100 Best Companies to Work For’ in 2025 by Fortune Media and Great Place to Work	04-02	BU
United Therapeutics Corporation to Present at the Leerink Partners Global Healthcare Conference 2025	03-04	BU
United Therapeutics: Q4 Earnings Snapshot	02-26	AQ
United Therapeutics : Fourth Quarter 2024 Factsheet	02-26	PU
United Therapeutics : Fourth Quarter 2024 Financial Results Presentation	02-26	PU
United Therapeutics Corporation Reports Fourth Quarter and Full Year 2024 Financial Results	02-26	BU
United Therapeutics Corporation to Present at the TD Cowen 45th Annual Health Care Conference	02-24	BU
United Therapeutics Corporation to Report Fourth Quarter and Full Year 2024 Financial Results Before the Market Opens on Wednesday, February 26, 2025	02-19	BU
United Therapeutics Corporation Announces Full Enrollment of the TETON 1 Study of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary Fibrosis	02-04	BU
United Therapeutics Corporation Announces FDA Clearance of its Investigational New Drug Application for the UKidney Xenotransplantation Clinical Trial	02-03	BU
United Therapeutics Corporation to Feature Clinical Data Across its Commercial and Development Portfolio at the Pulmonary Vascular Research Institute 2025 Annual Congress	01-21	BU
United Therapeutics Corporation to Present at the 43rd Annual J.P. Morgan Healthcare Conference	01-06	BU
United Therapeutics Announces Successful World's First UKidney Transplant	12-18	AQ
United Therapeutics Announces Successful World’s First UKidney Transplant	12-17	BU
United Therapeutics Corporation to Present at the UBS Global Healthcare Conference	11-05	BU
United Therapeutics : Third Quarter 2024 Factsheet	30/10/24	PU
United Therapeutics : Reports Third Quarter 2024 Financial Results Form 8 K	30/10/24	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

United Therapeutics delivers 18th consecutive quarter of topline growth

June 17, 2025 at 11:16 am